Will A. Robberts

Will is a co-founder and the President and Chief Financial Officer of LIPAC Oncology. He is a seasoned executive with extensive operational, financial and strategic leadership experience in various industries including healthcare, software and financial services. Will is a co-founder of LIPAC (and it’s affiliate, TesoRx Pharma) where he has led multiple strategic international licensing/partnering transactions, financings and manages the day-to-day operations. He also serves on the Board of Enable Biosciences, a DNA-conjugate based diagnostics company out of Stanford University. Prior to LIPAC, Will served as President of litigation software company, LiveNote, which he sold to Thomson Reuters and where he served as a Vice President focused on innovation and technology.

Will started his professional career at KPMG where he advised on multiple M&A and corporate finance transactions. He received a B.Comm, Honors and Masters Degree in Finance from Johannesburg University.